Makers of WHO approved vaccines should prioritise COVAX, not shareholder profit, says Tedros

The announcement by the WHO came after the Technical Advisory Group (TAG), an independent advisory committee of the world body recommended Emergency Use Listing(EUL) status for Covaxin, and days after the TAG sought "additional clarifications" from Bharat Biotech on October 26 to conduct a final "risk-benefit assessment" of the vaccine for global use.

from International-News-Economic Times https://ift.tt/3wi7LGh
via IFTTT

SHARE